A quantitative systems pharmacology modeling platform for evaluating triglyceride profiles in patients with high triglycerides receiving evinacumab
Abstract A model to quantitatively characterize the effect of evinacumab, an investigational monoclonal antibody against angiopoietin‐like protein 3 (ANGPTL3) on lipid trafficking is needed. A quantitative systems pharmacology (QSP) approach was developed to predict the transient responses of differ...
Guardado en:
Autores principales: | Masood Khaksar Toroghi, Jim Bosley, Lyn M. Powell, Yi Zhang, Feng Yang, Xia Pu, John D. Davis, Nidal Al‐Huniti |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Wiley
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f2c85718b9bd447bb1c865f81dfe8b6c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Population pharmacokinetics and exposure–response modeling for evinacumab in homozygous familial hypercholesterolemia
por: Xia Pu, et al.
Publicado: (2021) -
Genetic variation in SULF2 is associated with postprandial clearance of triglyceride-rich remnant particles and triglyceride levels in healthy subjects.
por: Niina Matikainen, et al.
Publicado: (2013) -
Pharmacological inhibition of adipose triglyceride lipase corrects high-fat diet-induced insulin resistance and hepatosteatosis in mice
por: Martina Schweiger, et al.
Publicado: (2017) -
Endothelial lipase mediates efficient lipolysis of triglyceride-rich lipoproteins.
por: Sumeet A Khetarpal, et al.
Publicado: (2021) -
Low HDL and high triglycerides predict COVID-19 severity
por: Lluís Masana, et al.
Publicado: (2021)